Skip to main content

Hydralazine Injection Shortage

Last Updated: June 6, 2017
Status: Resolved

Products Affected - Description
    • Hydralazine injection, Akorn, 20 mg/mL, 1 mL vial, 10 count, NDC 17478-0934-01
    • Hydralazine injection, American Regent, 20 mg/mL, 1 mL vial, 25 count, NDC 00517-0901-25
Reason for the Shortage
    • Akorn has hydralazine injection available.
    • American Regent has hydralazine injection on shortage due to manufacturing delays. This product has not been available for several years.
    • Fresenius Kabi has hydralazine injection available.
    • X-Gen launched hydralazine injection in September 2015.
Available Products
    • Hydralazine injection, Akorn, 20 mg/mL, 1 mL vial, 25 count, NDC 17478-0934-15
    • Hydralazine injection, Fresenius Kabi, 20 mg/mL, 1 mL vial, 25 count, NDC 63323-0614-01
    • Hydralazine injection, X-Gen, 20 mg/mL, 1 mL vial, 25 count, NDC 39822-0500-04

Estimated Resupply Dates

    • American Regent has hydralazine 20 mg/mL 1 mL vials on back order and the company cannot estimate a release date.
    • All other marketed presentations are available.

Updated

Updated June 6, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 12, 2014 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.